今日观察！A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

Shanghai, China - June 17, 2024 - A recent surge in investor sentiment towards growth stocks, particularly in the healthcare and technology sectors, has been dubbed the "Kete Valuation" phenomenon, named after the Chinese pharmaceutical company C-Bridge (6160.HK). This trend is reminiscent of the "CATL Valuation" rally that occurred in 2021, driven by the strong performance of Contemporary Amperex Technology Co., Ltd. (300015.SZ).

The "Kete Valuation" is characterized by a sharp increase in the share prices of companies with promising growth prospects, often defying broader market trends. This is evident in the recent performance of 50 stocks identified by analysts as having significant growth potential. These stocks, spanning various industries including healthcare, technology, and consumer goods, have exhibited remarkable resilience amidst recent market volatility.

Factors Driving the "Kete Valuation"

Several factors are contributing to the "Kete Valuation" trend. Firstly, investors are increasingly seeking out companies that can deliver sustainable growth, particularly in the face of global economic uncertainties. Secondly, the easing of monetary policy in major economies is providing a supportive backdrop for riskier assets like growth stocks. Additionally, advancements in technology and innovation are creating new opportunities for companies in various sectors, fueling investor optimism.

Key Beneficiaries of the "Kete Valuation"

Among the 50 stocks identified as potential beneficiaries of the "Kete Valuation," C-Bridge (6160.HK) stands out as a frontrunner. The company's innovative cancer therapies and strong pipeline of new drugs have attracted significant investor interest. Other notable stocks include:

• Ascletis Pharma (1672.HK): A clinical-stage biopharmaceutical company developing novel therapies for cancer and viral diseases.

• Aier Eye Hospital Group (300015.SZ): A leading provider of comprehensive eye care services in China.

• Xiaomi Corporation (1810.HK): A global technology company known for its smartphones, smart home devices, and internet services.

Investment Implications

The "Kete Valuation" presents an opportunity for investors to capitalize on the growth potential of select companies. However, careful due diligence is crucial, as not all growth stocks are created equal. Investors should thoroughly evaluate a company's financial health, competitive landscape, and long-term growth prospects before making investment decisions.

The "Kete Valuation" highlights the evolving dynamics of the Chinese stock market, where investors are increasingly discerning and seeking out companies with genuine growth potential. This trend is likely to continue as China's economy transitions towards a more innovation-driven and knowledge-based model.

备受期待的韩综《虽然没准备什么菜》第二季即将回归，李泳知携手BLACKPINK Jisoo开启美食新篇章

首尔 - 备受韩国观众喜爱的美食脱口秀节目《虽然没准备什么菜》第二季将于4月7日正式回归。由国民MC李泳知主持的该节目，以其轻松幽默的氛围和独特的美食形式吸引了众多粉丝。

在新一季节目中，李泳知将继续担任主持人，并邀请到各界知名人士作为嘉宾，共同分享美食和生活趣事。据悉，首位嘉宾将是韩国人气女团BLACKPINK的成员Jisoo。

在第一季节目中，李泳知以其不擅厨艺却热爱美食的形象，为观众带来了许多欢乐。她经常在节目中以各种奇葩的方式烹饪食物，并与嘉宾们展开爆笑互动。

除了李泳知之外，第二季节目还将邀请到更多重量级嘉宾，包括演员、歌手、综艺人等。据节目组透露，新一季节目将更加注重美食的制作过程，并为观众带来更多惊喜和创意。

《虽然没准备什么菜》第二季的回归，无疑将为韩国综艺市场注入新的活力。该节目不仅将为观众带来欢乐和美食体验，也将进一步推广韩国饮食文化。

以下是一些关于第二季节目可以期待的看点：

• 李泳知与BLACKPINK Jisoo的互动：Jisoo作为韩国当红女歌手，拥有超高的人气和影响力。她的加盟无疑将为节目带来更多关注和话题。
• 更丰富的美食体验：第二季节目将更加注重美食的制作过程，并为观众带来更多新颖的菜谱和烹饪技巧。
• 更具创意的节目形式：节目组将加入更多新颖的节目形式，为观众带来更加丰富的观看体验。

《虽然没准备什么菜》第二季将于4月7日起每周四晚上7点在YouTube频道播出。 期待李泳知和她的嘉宾们为大家带来更多美食和欢乐！